Samuel Waksal

Samuel Waksal is the Chief Executive Officer at Graviton Bioscience, where the focus is on curing diseases through restored homeostasis. With a background in immunology from The Ohio State University College of Medicine, Samuel has founded and held various leadership positions in companies like Graviton Biopharmaceuticals Corporation, BRAIN-MIND INSTITUTE, and Appel Alzheimer's Research Institute. Samuel is dedicated to working in novel areas of signaling disorders of the immune system, the brain, and neurodegenerative diseases.